investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts

Charles M. Rudin

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Javed Khan

Targeting FGFR4, RAS, and PAX3-FOXO1 Gene in Rhabdomyosarcoma

Trachea, bronchus and lung

Pediatric oncology or childhood cancer

Stephen Scwartz

EXPANDING SEER TO INCLUDE MOLECULAR PROFILING IN NON-SMALL CELL LUNG CANCER (NSCLC)

Trachea, bronchus and lung

David Kozono

Characterization of lung cancer radiosensitizers from genome-wide RNAi screens

Trachea, bronchus and lung

Yanxiang Guo

The role of autophagy in Kras-driven lung cancer

Trachea, bronchus and lung

Pathology

Susan Bates

Clinical Studies to Circumvent Drug Resistance

Trachea, bronchus and lung

David FitzGerald

Bio-Therapies for the Treatment of Cancer

Trachea, bronchus and lung

Eric Haura

Specialized Program of Research Excellence (SPORE) in Lung Cancer

Trachea, bronchus and lung

Pathology

Jeffrey Schlom

Strategies for Cancer Vaccine Development: Preclinical Studies

Trachea, bronchus and lung

Pathology

Michael J Eck

Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma

Trachea, bronchus and lung